Salzman Group
Founded 1996
About Salzman Group
The Salzman Group is a global drug development company that seeks to transform medical practice by undertaking transformative pharmaceutical innovation. They meet this objective by creating and developing our own drugs and those of others, serving both as an internal research engine and as a boutique contract service organization. For more than 25 years, the scientific team at Salzman Group has worked as a close-knit group, building a reputation for global leadership in basic science, drug development, and clinical medicine. Our expertise and professional network enable us to create groundbreaking opportunities that tackle unmet medical needs, and to customize support for our clients to overcome their drug development challenges. In the process, they have raised hundreds of millions of dollars for our own efforts and those of our clients, and have pioneered new pharmaceutical technologies resulting in strategic exits, initial public offerings, grant and contract funding, and intellectual property. Whether working with our own drugs or those of our clients, They have only one goal: to focus on pursuing discovery and development that will change the nature of 21st century medicine.
Company Facts
- Founded: 1996
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Website: salzmangrp.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/salzman-group-8380270 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.